Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Maguire

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
FEBS Letters|October 9, 1989
EPR characterization of soluble fragments of succinate dehydrogenase from mutant strains of Bacillus subtilisJ J Maguire, L Hederstedt
British Journal of Pharmacology|May 1, 1995
ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitroJ J Maguire, A P Davenport
Trends in Pharmacological Sciences|February 26, 2000
Urotensin II: fish neuropeptide catches orphan receptorA P Davenport, J J Maguire
Expert Opinion on Investigational Drugs|July 5, 2005
The therapeutic potential of PD156707 and related butenolide endothelin antagonistsJ J Maguire, A P Davenport
Handbook of Experimental Pharmacology|September 27, 2006
EndothelinA P Davenport, J J Maguire
British Journal of Pharmacology|October 24, 1998
Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in diseaseJ J Maguire, A P Davenport
Trends in Pharmacological Sciences|January 1, 1994
Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans?A P Davenport, J J Maguire
British Journal of Pharmacology|August 19, 2014
Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12J J Maguire, A P Davenport
Journal of Cardiovascular Pharmacology|November 15, 2000
No alteration in vasoconstrictor endothelin-B-receptor density or function in human coronary artery diseaseJ J Maguire, A P Davenport
Current Opinion in Pharmacology|November 21, 2001
The endothelin system in human saphenous vein graft diseaseA P Davenport, J J Maguire
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
FEBS Letters|October 9, 1989
EPR characterization of soluble fragments of succinate dehydrogenase from mutant strains of Bacillus subtilisJ J Maguire, L Hederstedt
British Journal of Pharmacology|May 1, 1995
ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitroJ J Maguire, A P Davenport
Trends in Pharmacological Sciences|February 26, 2000
Urotensin II: fish neuropeptide catches orphan receptorA P Davenport, J J Maguire
Expert Opinion on Investigational Drugs|July 5, 2005
The therapeutic potential of PD156707 and related butenolide endothelin antagonistsJ J Maguire, A P Davenport
Handbook of Experimental Pharmacology|September 27, 2006
EndothelinA P Davenport, J J Maguire
British Journal of Pharmacology|October 24, 1998
Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in diseaseJ J Maguire, A P Davenport
Trends in Pharmacological Sciences|January 1, 1994
Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans?A P Davenport, J J Maguire
British Journal of Pharmacology|August 19, 2014
Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12J J Maguire, A P Davenport
Journal of Cardiovascular Pharmacology|November 15, 2000
No alteration in vasoconstrictor endothelin-B-receptor density or function in human coronary artery diseaseJ J Maguire, A P Davenport
Current Opinion in Pharmacology|November 21, 2001
The endothelin system in human saphenous vein graft diseaseA P Davenport, J J Maguire
Pageof 7